Skip to main content
Supplement ScienceSupplementScience
meta analysis875 participants

Chromium for Blood Sugar Control: What the Meta-Analyses Show (Mixed Evidence)

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

The evidence is mixed.

The evidence is mixed. A 2020 meta-analysis found chromium was associated with reduced HbA1c and fasting glucose in type 2 diabetes, while a 2015 meta-analysis (875 participants) found most chromium forms had no significant effect on HbA1c. Any benefit appears modest and form-dependent, so chromium is not a substitute for prescribed diabetes care.

Key Findings

  • A 2020 meta-analysis (Asbaghi et al., 28 trials) found chromium supplementation was associated with reduced HbA1c (about −0.71%) and fasting plasma glucose (about −19 mg/dL) in type 2 diabetes.
  • A 2015 meta-analysis (Yin & Phung, 14 trials, 875 participants) found most chromium forms showed NO statistically significant effect on HbA1c, with only a marginal fasting-glucose benefit from one form (brewer's yeast).
  • Heterogeneity across trials was very high, and effects appear to depend on the chromium form and dose.
  • Overall the evidence is mixed, and any glycemic benefit appears modest at best.

Study Details

Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus
Yin RV, Phung OJNutrition Journal (2015)
Across 14 RCTs (875 participants), most chromium forms showed no statistically significant effect on HbA1c; only brewer's yeast showed a marginal fasting-glucose reduction.
875 participantsModerate

Practical Takeaway

Chromium has been studied for supporting blood-sugar control in type 2 diabetes, but the meta-analytic evidence is genuinely mixed — one analysis found reductions in HbA1c and fasting glucose, while another found little effect for most chromium forms. Any benefit appears modest and may depend on the specific form and dose. Chromium is not a substitute for prescribed diabetes treatment, monitoring, or lifestyle care. If you have diabetes, discuss any supplement with your clinician, since blood-sugar management should be individualized and supervised.

Summary

Meta-analyses of chromium for type 2 diabetes are mixed — one found reductions in HbA1c and fasting glucose, another found little effect for most forms — so any benefit appears modest at best.

Related Supplements

Related Conditions

Learn More

Frequently Asked Questions

Does chromium help control blood sugar in diabetes?

The evidence is mixed. One meta-analysis found chromium was associated with lower HbA1c and fasting glucose, while another found no significant effect for most chromium forms. Any benefit appears modest and form-dependent, so chromium is best viewed as a possible adjunct, not a reliable treatment.

How much chromium was studied, and which form?

Trials used a wide range of doses (about 50–1,000 mcg/day) and different forms (such as chromium picolinate and brewer's yeast). Results varied by form, which is one reason the overall evidence is inconsistent. A clinician can advise whether it is appropriate for you.

Can chromium replace my diabetes medication?

No. Chromium is studied as a possible adjunct, not a replacement for prescribed diabetes treatment, monitoring, or lifestyle measures. Do not change diabetes medication based on supplement use — work with your clinician.

Is chromium supplementation safe?

Chromium is generally considered low-risk at typical supplemental doses, but because it can affect blood sugar and the evidence is mixed, anyone with diabetes should use it only with clinician guidance and continued blood-sugar monitoring.

Continue Reading

References

  1. Yin RV, Phung OJ (2015). Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus. Nutrition Journal. DOI PubMed
  2. Asbaghi O, Fatemeh N, Mahnaz RK, Ehsan G, Elham E, Behzad N, Damoon AL, Amirmansour AN (2020). Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacological Research. DOI PubMed